We are live on
!
Find out more
SGAM
Smith Group Asset Management Portfolio holdings
AUM
$2.46B
Turnover
25.53%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+9.97%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.99B
AUM Growth
-$263M
(-8.1%)
Cap. Flow
-$458M
Cap. Flow
% of AUM
-15.28%
Top 10 Holdings %
Top 10 Hldgs %
28.23%
Holding
498
New
54
Increased
54
Reduced
221
Closed
53
Avg Time Held
1.6
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$63.6M |
| 2 |
Travel + Leisure Co
TNL
|
+$47.7M |
| 3 |
Procter & Gamble
PG
|
+$26.9M |
| 4 |
Biogen
BIIB
|
+$24.9M |
| 5 |
Hilton Worldwide
HLT
|
+$22.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$54.3M |
| 2 |
General Dynamics
GD
|
+$32M |
| 3 |
Hologic
HOLX
|
+$31M |
| 4 |
BWX Technologies
BWXT
|
+$30.4M |
| 5 |
VeriSign
VRSN
|
+$29.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.65% |
| 2 | Consumer Discretionary | 17.93% |
| 3 | Healthcare | 16.34% |
| 4 | Industrials | 13.41% |
| 5 | Communication Services | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Manulife Financial
MFC
$72.6B
| $590K | 0.02% |
29,100
| – | – |
2017 Q1
2 quarters
|
|
202
Accenture
ACN
$138B
| $589K | 0.02% |
4,360
| – | – |
2016 Q4
3 quarters
|
|
203
Canadian Imperial Bank of Commerce
CM
$102B
| $582K | 0.02% |
13,292
| – | – |
2016 Q3
4 quarters
|
|
204
DELISTED
Blueprint Medicines
BPMC
| $575K | 0.02% |
+8,250
| New | +$441K |
2017 Q3
0 quarters
|
|
205
Grupo Aeroportuario Centro Norte
OMAB
$4.41B
| $558K | 0.02% |
12,560
| – | – |
2013 Q3
16 quarters
|
|
|
SHI
206
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
| $537K | 0.02% |
8,980
| – | – |
2016 Q1
6 quarters
|
|
207
Ligand Pharmaceuticals
LGND
$5.95B
| $534K | 0.02% |
6,284
| – | – |
2016 Q1
6 quarters
|
|
208
Marriott Vacations Worldwide
VAC
$3.86B
| $532K | 0.02% |
4,270
+655
| +18% | +$75.4K |
2015 Q3
8 quarters
|
|
209
First Financial Bankshares
FFIN
$4.53B
| $519K | 0.02% |
22,984
+3,504
| +18% | +$73.4K |
2017 Q2
1 quarter
|
|
210
Telkom Indonesia
TLK
$12.6B
| $519K | 0.02% |
15,120
| – | – |
2013 Q2
17 quarters
|
|
|
AVXS
211
DELISTED
AveXis, Inc. Common Stock
AVXS
| $516K | 0.02% |
+5,330
| New | +$481K |
2017 Q3
0 quarters
|
|
|
PTLA
212
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $511K | 0.02% |
9,460
| – | – |
2017 Q1
2 quarters
|
|
213
Dana Inc
DAN
$3.06B
| $478K | 0.02% |
17,096
+2,585
| +18% | +$62.7K |
2015 Q1
10 quarters
|
|
214
DELISTED
Amicus Therapeutics
FOLD
| $474K | 0.02% |
31,400
| – | – |
2017 Q2
1 quarter
|
|
215
DELISTED
bluebird bio
BLUE
| $470K | 0.02% |
264
| – | – |
2017 Q1
2 quarters
|
|
216
Halozyme
HALO
$13.8B
| $469K | 0.02% |
26,980
| – | – |
2015 Q3
8 quarters
|
|
|
ONCE
217
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $457K | 0.02% |
+5,130
| New | +$390K |
2017 Q3
0 quarters
|
|
218
Ultragenyx Pharmaceutical
RARE
$1.5B
| $455K | 0.02% |
8,550
| – | – |
2015 Q4
7 quarters
|
|
219
DELISTED
Taylor Morrison
TMHC
| $447K | 0.01% |
20,286
+3,103
| +18% | +$68.6K |
2017 Q2
1 quarter
|
|
220
Prothena Corp
PRTA
$436M
| $437K | 0.01% |
6,740
| – | – |
2015 Q4
7 quarters
|
|
221
Ironwood Pharmaceuticals
IRWD
$623M
| $432K | 0.01% |
32,692
| – | – |
2016 Q1
6 quarters
|
|
222
Home BancShares
HOMB
$5.78B
| $431K | 0.01% |
17,095
-53,455
| -76% | -$1.28M |
2015 Q3
8 quarters
|
|
223
DELISTED
Sage Therapeutics
SAGE
| $426K | 0.01% |
6,840
| – | – |
2016 Q4
3 quarters
|
|
224
Sarepta Therapeutics
SRPT
$1.88B
| $415K | 0.01% |
9,160
| – | – |
2016 Q4
3 quarters
|
|
|
LOXO
225
DELISTED
Loxo Oncology, Inc
LOXO
| $408K | 0.01% |
+4,430
| New | +$344K |
2017 Q3
0 quarters
|
|
Similar funds
MAMU
PC
RG
DIA
Smith Group Asset Management's Q3 2017 Portfolio in Review
As of Q3 2017, Smith Group Asset Management held 498 positions worth $2.99B, down 8.1% from $3.26B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Smith Group Asset Management withdrew a net $458M in Q3 2017, closing 53 positions and reducing 221 holdings. Its most notable exit was Citrix Systems Inc, an estimated $54.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Smith Group Asset Management opened a new position in Procter & Gamble worth $26.9M.
- Smith Group Asset Management's largest Q3 2017 buy was Procter & Gamble: 295,298 shares worth $26.9M.
- Smith Group Asset Management added most to Boeing in Q3 2017, an estimated $63.6M increase.
- Smith Group Asset Management's biggest Q3 2017 reduction was Rockwell Automation, cutting an estimated $28.9M.
- Smith Group Asset Management fully exited Citrix Systems Inc in Q3 2017, selling an estimated $54.3M.
- Smith Group Asset Management's ten largest holdings make up 28% of its $2.99B portfolio in Q3 2017.
- Smith Group Asset Management opened 54 new positions and closed 53 in Q3 2017.
- Smith Group Asset Management's portfolio value fell 8.1% quarter-over-quarter to $2.99B.
Based on Smith Group Asset Management's 13F filing for Q3 2017, filed 2 Nov 2017.